Butterfield JH - Search Results

1

Chemotherapy Acute Infusion Reactions: A Qualitative Report of the Perspectives of Patients With Cancer.

Bartlett DJ, Childs DS, Breitkopf CR, Grudem ME, Mitchell JL, Looker SA, Ridgeway JL, Lee JL, Butterfield JH, Weroha SJ, Jatoi A. Bartlett DJ, et al. Among authors: butterfield jh. Am J Hosp Palliat Care. 2018 Nov;35(11):1384-1389. doi: 10.1177/1049909118773995. Epub 2018 May 3. Am J Hosp Palliat Care. 2018. PMID: 29724109

2

Response of patients with indolent systemic mastocytosis to tamoxifen citrate.

Butterfield JH, Chen D. Butterfield JH, et al. Leuk Res. 2016 Jan;40:10-6. doi: 10.1016/j.leukres.2015.11.004. Epub 2015 Nov 4. Leuk Res. 2016. PMID: 26612479

3

Successful rapid desensitization to temozolomide: A case series.

Divekar R, Butterfield J, Maddox D. Divekar R, et al. J Allergy Clin Immunol Pract. 2016 May-Jun;4(3):545-6. doi: 10.1016/j.jaip.2015.12.007. Epub 2016 Jan 20. J Allergy Clin Immunol Pract. 2016. PMID: 26868726 No abstract available.

4

Rituximab in a patient with splenic marginal zone lymphoma and acquired angioedema.

Motosue MS, Howard MT, Butterfield JH. Motosue MS, et al. Among authors: butterfield jh. Ann Allergy Asthma Immunol. 2016 May;116(5):472-3. doi: 10.1016/j.anai.2016.03.003. Epub 2016 Mar 24. Ann Allergy Asthma Immunol. 2016. PMID: 27017557 No abstract available.

5

Pharmacological treatment options for mast cell activation disease.

Molderings GJ, Haenisch B, Brettner S, Homann J, Menzen M, Dumoulin FL, Panse J, Butterfield J, Afrin LB. Molderings GJ, et al. Naunyn Schmiedebergs Arch Pharmacol. 2016 Jul;389(7):671-94. doi: 10.1007/s00210-016-1247-1. Epub 2016 Apr 30. Naunyn Schmiedebergs Arch Pharmacol. 2016. PMID: 27132234 Free PMC article. Review.

6

Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: A Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & Immunology.

Carter MC, Metcalfe DD, Matito A, Escribano L, Butterfield JH, Schwartz LB, Bonadonna P, Zanotti R, Triggiani M, Castells M, Brockow K. Carter MC, et al. Among authors: butterfield jh. J Allergy Clin Immunol. 2019 Mar;143(3):880-893. doi: 10.1016/j.jaci.2018.10.063. Epub 2018 Dec 6. J Allergy Clin Immunol. 2019. PMID: 30528617 Review.

7

Response of six patients with idiopathic hypereosinophilic syndrome to interferon alfa.

Butterfield JH, Gleich GJ. Butterfield JH, et al. J Allergy Clin Immunol. 1994 Dec;94(6 Pt 2):1318-26. doi: 10.1016/0091-6749(94)90348-4. J Allergy Clin Immunol. 1994. PMID: 7798572 Clinical Trial. No abstract available.

8

In vitro sensitivity of immature human mast cells to chemotherapeutic agents.

Butterfield JH, Weiler DA. Butterfield JH, et al. Int Arch Allergy Appl Immunol. 1989;89(2-3):297-300. doi: 10.1159/000234963. Int Arch Allergy Appl Immunol. 1989. PMID: 2759719

9

Success of short-term, higher-dose imatinib mesylate to induce clinical response in FIP1L1-PDGFRalpha-negative hypereosinophilic syndrome.

Butterfield JH. Butterfield JH. Leuk Res. 2009 Aug;33(8):1127-9. doi: 10.1016/j.leukres.2008.12.001. Epub 2009 Jan 13. Leuk Res. 2009. PMID: 19144405

10

Clonal mast cell disease not meeting WHO criteria for diagnosis of mastocytosis: clinicopathologic features and comparison with indolent mastocytosis.

Pardanani A, Chen D, Abdelrahman RA, Reichard KK, Zblewski D, Wood AJ, McClure RF, Butterfield JH, Hanson CA, Tefferi A. Pardanani A, et al. Among authors: butterfield jh. Leukemia. 2013 Oct;27(10):2091-4. doi: 10.1038/leu.2013.227. Epub 2013 Jul 30. Leukemia. 2013. PMID: 23896642 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters